Michael Patrick Hultin

Michael Hultin practices at Kaweah Health Medical Center in Visalia, California, part of Kaweah Delta Health Care District.

Michael Hultin's NPI, 1952866451, was assigned on February 8, 2019. Michael Hultin holds California license 95011106.

Michael Hultin's primary practice is Kaweah Health Medical Center, at 400 W Mineral King Ave, Visalia, CA 93291 in Tulare County. The practice phone is (559) 624-2000.

Michael Hultin's primary practice is Kaweah Health Medical Center in Visalia, California, part of Kaweah Delta Health Care District. Michael Hultin is also affiliated with Adventist Health Hanford. The medical group on file is Valley ENT. Dmand AI also links Michael Hultin to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Hultin practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Michael Hultin's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Michael Hultin is licensed in California.

Dmand AI lists acute skin infection, chronic ear infection, chronic nasal allergies, chronic sinusitis, rash, swimmer's ear, tobacco use and underactive thyroid among the conditions Michael Hultin treats.

CMS data shows 1,351 Medicare services from Michael Hultin across 7 procedure codes in 2024, for 408 Medicare patients. Medicare paid $102,999 for them. Every service was in an office.

CMS counts 408 Medicare patients who saw Michael Hultin in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Hultin's median patient age at 49, with 58% women.

In 2024, Michael Hultin wrote 1,376 Medicare Part D claims for 426 patients. 98% of them were for generic drugs. CMS names the drug for 1,236 of them, across 20 drugs with 11 or more claims each, at $23,506 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Michael Hultin for performance year 2024, reported individually. Michael Hultin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 36 general payments to Michael Hultin from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 89% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $318.